The present invention discloses novel isoquinoline carboxamide derivatives which are HIV protease inhibitors or prodrugs thereof, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are hydroxyethylamine tripeptide mimetics which act as inhibitors of the HIV aspartyl protease, an essential enzyme in the replicative life cycle of HIV. Consequently, the compounds of this invention may be advantageously used in the treatment of HIV infection, either alone or in combination with other inhibitors of HIV viral replication or with pharmacoenhancers such as cytochrome P450 inhibitors.
本发明公开了新型
异喹啉羧酰胺衍
生物,其为HIV蛋白酶抑制剂或其前药,以及其制备方法、药物组合物和在医学中使用这些化合物的用途。具体而言,这些化合物是羟乙基胺三肽类似物,可作为HIV
天冬氨酸蛋白酶的
抑制剂,该酶是HIV复制生命周期中不可或缺的酶。因此,本发明的化合物可以有益地用于治疗HIV感染,可以单独使用,也可以与其他HIV病毒复制
抑制剂或细胞色素P450
抑制剂等药物增强剂联合使用。